Recital 4, Regulation (EU) 2024/1054

In forcesince 10 Apr 2024

The European Food Safety Authority (‘the Authority’) concluded in its opinion of 26 September 2023 [EFSA Journal 2023;21(11):8355.] that, under the proposed conditions of use, the preparation of Weizmannia faecalis DSM 32016 is safe for the target species, the consumers and the environment. It also concluded that the preparation of Weizmannia faecalis DSM 32016 is not a skin/eye irritant but is a respiratory sensitiser. The Authority could not conclude on the skin sensitisation potential of that preparation. The Authority concluded that the preparation is considered to be efficacious in feed for poultry reared for laying or breeding and in water for drinking for poultry species reared for fattening, poultry reared for laying/breeding, ornamental birds and suckling and weaned Suidae piglets. In addition, it indicated that the preparation of Weizmannia faecalis DSM 32016 is compatible with the coccidiostats halofuginone, diclazuril, monensin sodium, robenidine hydrochloride, salinomycin sodium a combination of monensin sodium with nicarbazin, but not with narasin or a combination of narasin with nicarbazin, while no conclusions could be drawn on its compatibility with decoquinate, lasalocid A sodium, semduramicin sodium, nicarbazin or amprolium hydrochloride. The Authority did not consider that there is a need for specific requirements of post-market monitoring.